TITLE:
Multi-Systemic Inflammatory Syndrome in Children
AUTHORS:
Ilham Tadmori, Soukaina Seddiki, Samir Atmani, Moustapha Hida
KEYWORDS:
Multisystemic Inflammatory Syndrome, Child, COVID-19, PIMS
JOURNAL NAME:
Open Journal of Pediatrics,
Vol.13 No.4,
July
21,
2023
ABSTRACT: The objective of our work is to study the multi-systemic inflammatory
syndrome (PIMS) in children, to determine its frequency, by analyzing the
epidemiological, clinical, paraclinical, therapeutic, and evolutionary profile
of these patients. A retrospective study spanning a period of 2 years from
April 2020 to March 2022. It concerns all children under the age of 16 admitted
and cared for in the pediatric emergency department of the university hospital
Hassan II of Fez for multi-system inflammatory syndrome (PIMS). Twenty cases of PIMS were collected over this period.
Multi-system inflammatory syndrome in children has been described in temporal
association with COVID-19, usually within 2 to 6 weeks of illness or
exposure. The age of the patients varies between 8 months and 15 years. All
patients presented with fever and cutaneous signs, followed by digestive signs
and neurological signs. The inflammatory syndrome is frankly positive in all
patients who had a COVID-19 PCR and/or positive serology. The treatment is
based on the administration of immunoglobulins
in association with corticosteroid therapy and non-specific antibiotic
therapy in the majority of cases (80%). The evolution was favorable. PIMS
should be considered in all children presenting with a clinical and/or
biological inflammatory syndrome associated with COVID-19.